Heart Disease Trial, Recruiting NCT06593223 Sponsor: The University of Hong Kong-Shenzhen Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06593223
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are experiencing acute (sudden or severe) heart failure
  • People who have chronic (long-term) heart failure that has been stabilised and are being managed as outpatients
  • People who are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People under 18 years of age
  • People who were born with certain structural heart conditions, such as tetralogy of Fallot, a hole between the heart chambers, Fontan circulation, or a single-chamber heart condition
  • People who have an artificial mechanical heart valve, a pacemaker, or an implanted cardiac defibrillator (ICD) device
  • People who have significant back problems that prevent them from lying flat on a bed
  • People who are pregnant
  • People who weigh less than 35 kg or more than 150 kg
  • People who are already connected to another medical device that would prevent the study's testing device from being used

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Hong Kong-Shenzhen Hospital
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
1 July 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Noninvasive filling pressure testing has clinical significance consistent with NT-proBNP and CCS scores to reflect congestion in acute heart failure.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov